@FierceMedDev: J&J device revenue jumped 6.4% in 2012 thanks to Synthes buy. Report | Follow @FierceMedDev
@DamianFierce: If $LIFE is indeed for sale, that's not stopping it from pursuing more M&A of its own. More | Follow @DamianFierce
> Medtronic ($MDT) is working to expand its O-Arm Intra-operative 3-D surgical imaging device in India, in keeping with CEO Omar Ishrak's goal of boosting the company's presence in emerging markets. Article
> SafeStitch Medical got some positive results for its GERD- and obesity-treating device, and the company is planning to submit an IDE this year and pursue full FDA approval. More
> Hospira ($HSP) has entered into a deal with Q Core Medical, giving the company exclusive rights to market and distribute Q Core's Sapphire infusion pump. The agreement opens up a revenue stream for Hospira after the FDA blocked the importation of its Symbiq pumps back in November. News | Background
> Moog Medical Devices is expanding its recall of administration sets to include another production lot. Item
> Mallinckrodt, Covidien's ($COV) soon-to-be-spun-out drug business, got FDA approval for a prefilled-syringe variety of Gablofen, a treatment for spinal spasticity. Release
> Teleflex ($TFX) snagged FDA clearance for its Arrow UltraQuik peripheral nerve block needles. Report
> Israel's Brainsway ($BRIN) expects to find a commercialization partner this quarter for its recently FDA-approved device to treat depression. Story
Biotech News
@FierceBiotech: Novo Nordisk nabs European OK on blockbuster diabetes drug hopeful. News | Follow @FierceBiotech
@JohnCFierce: As CRL letters go, Impax would seem to have a low hurdle ahead on its sustained release Parkinson's drug. More | Follow @JohnCFierce
@RyanMFierce: Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article | Follow @RyanMFierce
> New $80M venture fund to back startups entering 'valley of death.' Story
> Biotech vet Astley-Sparke takes U.S. lead for pioneering gene therapy player. Article
Pharma News
@FiercePharma: ADHD diagnoses up 24% over past 10 years; study author cites "better diagnosis" and possible "upward trend." More | Follow @FiercePharma
@AlisonBFierce: Vanderbilt University has emerged as a leading institution for central nervous system drug research and discovery. Editor's Corner | Follow @AlisonBFierce
@EricPFierce: Plant problems stymie Impax NDA for Parkinson drug, FDA says. Article | Follow @EricPFierce
> Amgen's Sensipar scored pricing shield from Congress. News
> Novo ready to rev up Tresiba for European launch. Report
Biotech IT News
> New chief named for Perceptive Informatics. Story
> U.K. regulator finds social media groove…finally. Item
> Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article
> Elsevier rumored as potential buyer of open science startup. News
CRO News
> Is GlaxoSmithKline stretching its contractors too thin? Story
> Covance teams with U.K.'s NHS Trust on Phase I trials. Report
> Clinipace rejiggers eClinical platform. Article
> Quintiles lands pathology accreditation for Indian lab. News
Pharma Manufacturing News
> BASF lands Pronova making it a top omega-3 maker. Report
> Pfizer to develop laser cleaning verification system. Item
> Cargo theft down in year of key arrests. News
> Plant problems stymie Impax NDA, FDA says. Article
Biotech Research News
> Calcium receptor could stop sleeping sickness in its tracks. Item
> Oral breast cancer vaccine could prevent recurrence. Article
> A great leap forward: Microdystrophin gene therapy success in dogs. Report
> Glowing mice could blaze way for detecting, tracking cancer growth. News